There was no difference in the immunological interventions administered to the two groups, but a poorer response to treatment (OR = 2.78; 95% CI = 0.88–9.09) and more deaths (OR = 2.38; 95% CI = 0.67–8.33) were noted among the antibody-negative than antibody-positive patients although it did not reach statistical significance.
1
—
—